Bolt Biotherapeutics logo

Bolt Biotherapeutics Funding & Investors

Bolt Biotherapeutics, Inc. operates as a biotechnology company. The Company develops immune-stimulating antibody conjugates, a new class of cancer therapeutics, which systemically-administered and uncover the immune system to induce anti-tumor immunity. Bolt Biotherapeutics serves healthcare industry in the United States.

boltbio.com

Total Amount Raised: $198,500,000

Bolt Biotherapeutics Funding Rounds

  • Post Ipo Equity

    $15,000,000

    Post Ipo Equity Investors

    Genmab
  • Series C

    $93,500,000

    Series C Investors

    Novo Holdings
    Vivo Capital
    Sofinnova
    Pfizer Venture Investments
    Rock Springs Capital
    RA Capital Management
    Samsara BioCapital
    Pivotal bioVenture Partners
    Surveyor Capital
  • Series B

    $54,000,000

    Series B Investors

    Nan Fung Life Sciences
    Novo Holdings
    Vivo Capital
    Pivotal bioVenture Partners
  • Series Unknown

    $19,400,000

  • Series Unknown

    $6,000,002

  • Series Unknown

    $9,999,998

  • Seed

    $600,000

  • IPO

    Unknown

Funding info provided by Diffbot.